|Day Low/High||9.99 / 10.35|
|52 Wk Low/High||9.25 / 28.97|
Follow these maxims and you should do well in this volatile sector.
Energy stocks were hammered and pulled benchmark indexes lower by midday Monday.
Wal-Mart sets the tone, but selling hasn't been bad enough to kill rally.
Jim Cramer answers viewers questions from social media on the floor of the New York Stock Exchange.
Signs of support on the S&P, but there is a lot of uncertainty.
The selloff in immunotherapy stocks is purely market-based and does not reflect the stunning advances in the cancer fighting space, said Dr. Andre Choulika, CEO of Cellectis S.A.
Investors are most excited about Bluebird Bio (BLUE) and Pacira Pharmaceuticals (PCRX), according to Wedbush Securities, which is holding its annual healthcare investment conference in New York.
I have about 25% in cash; if the market falls 5-10%, I'm in.
Today's selling was steady; question is how long it will persist.
Only one fund category (of 20) has beaten the S&P 500 over half a decade.
Market still looks like it will open up February with a minor rally based on premarket futures. ExxonMobil (XOM) reported results that beat on the bottom line slightly and just missed on revenue expectations. Stock is up premarket; let's see what de...